▮ More

Intraday Alerts

Las Vegas Sands Rally Continues

By RTTNews Staff Writer ✉ | Published: 12/27/2022 10:42 AM ET

Las Vegas Sands Corp. (LVS) shares are up more than 4 percent on Tuesday morning trade after the company, continuing a surge since December 23. There have been no corporate announcements to influence the stock movement today.

Currently, shares are at $48.63, up 4.50 percent from the previous close of $46.52 on a volume of 1,813,424.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Biotech Investor.

Biotech Stocks Facing FDA Decision In March 2023

Biotech Stocks Facing FDA Decision In February 2023

Biotech stocks Facing FDA Decision in January 2023

Latest Updates on COVID-19

Biden Signs Covid Origins Bill Into Law

34% Fall In US Covid Cases, 38% Fall In Deaths In Last 2 Weeks

FDA Authorizes Bivalent Pfizer Covid Vaccine As Booster Dose For Select Children Under 5

Covid Cases, Hospitalizations Fall Nationwide In Last 2 Weeks

FDA Authorizes First At-Home Test To Detect Flu And COVID-19

COVID-19: Drugs in Development

FDA Clears Eat Just's Good Meat Cultivated Chicken

Attorneys General Of 23 US States Urge Hyundai, Kia To Take Swift Action Against Car Thefts

Kagome Worcester, Chuno, Take Out Tonkatsu Sauces Recalled

Domino's Offering 50% Off Menu-Priced Pizzas Through March 26

FDA Bans 2 Vuse Solo Menthol E-cigarette Products

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Hoyo, SBC Recalls Frozen, Ready-To-Eat Beef Sambusa Product

Mockingbird Expands Recall To Include Single Strollers

Las Vegas Sands Rally Continues

FDA Clears Eat Just's Good Meat Cultivated Chicken

Attorneys General Of 23 US States Urge Hyundai, Kia To Take Swift Action Against Car Thefts

Kagome Worcester, Chuno, Take Out Tonkatsu Sauces Recalled

Domino's Offering 50% Off Menu-Priced Pizzas Through March 26

FDA Bans 2 Vuse Solo Menthol E-cigarette Products

Foot Locker Q4 Profit Down, Warns On FY23; To Close Hong Kong Operations

Hoyo, SBC Recalls Frozen, Ready-To-Eat Beef Sambusa Product

Mockingbird Expands Recall To Include Single Strollers

First Republic Bank Secures $30 Bln Rescue Fund From Major US Banks

Kirkland Signature Frozen Organic Strawberries Sold By Costco Recalled

Polaris Recalls Sportsman All-Terrain Vehicles

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

Kirkland Signature Frozen Organic Strawberries Sold By Costco Recalled

Pearson In Deal To Sell Pearson Online Learning Services To Regent

Zai Lab Partner Karuna's Phase 3 Trial Of KarXT In Schizophrenia Meets Primary Endpoint

PDD Holdings Q4 Profit Rises 43%

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

First Republic Bank Secures $30 Bln Rescue Fund From Major US Banks

SVB Financial Group Files For Reorganization Under Chapter 11

FDA Bans 2 Vuse Solo Menthol E-cigarette Products

Ducommun To Acquire BLR Aerospace - Quick Facts

Coya Therapeutics In Deal With Dr. Reddy's To License Proposed Biosimilar Abatacept For Coya 302

Liberty Global Announces Intended Offer For Telenet

Novartis: SMA Drug Zolgensma Long-term Data Shows Sustained Durability Up To 7.5 Years Post-dosing

NuVasive Receives Expanded Clearance From FDA For Precice Limb Lengthening Solution

Kenmare Resources Plc FY Pretax Profit Rises

European Commission Approves Acquisition Of VOO And Brutélé By Orange - Quick Facts

Pendragon FY22 Earnings Drop, But Revenue Climbs; Says Confident Of FY23

Kingfisher FY Adj. Post-tax Profit Declines; LFL Sales Down 2.1%

ITT Ink 10-Year Strategic Agreement With Continental To Supply Aftermarket Brake Pads

SVB Financial Group Files For Reorganization Under Chapter 11

Kite Reports Primary Overall Survival Analysis Results Of Phase 3 ZUMA-7 Study

Knight-Swift To Acquire U.S. Xpress Enterprises For Enterprise Value Of $808 Mln

X5 Retail Group FY22 Net Profit Rises; Revenue Up 18.2%

Coya Therapeutics In Deal With Dr. Reddy's To License Proposed Biosimilar Abatacept For Coya 302